Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better

Cathie Wood is loading up on shares of a biotech that could be one of the first entrants to the psychedelics market.